Previous 10 | Next 10 |
Catalent, Inc. (“Catalent” or the “Company”) (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that, on September 14, 2023, it received a notice (the “NYSE Notice”) from the New Yo...
2023-09-15 06:46:50 ET More on market strategy Fund managers finally embrace U.S. stocks Key Region Of Support Sides With SPY Bullish Case Market Crosswinds And Nasdaq Looking Better Than Dow Seeking Alpha’s Quant Rating on SPDR S&P 500 Trust ETF ...
2023-09-07 12:42:08 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips S&P 500 companies collectively saw second-quarter earnings fall by 4% over last year. A big problem for the index constituents is the higher interest expenses that are eat...
2023-09-05 13:12:27 ET More on Catalent Seeking Alpha’s Quant Rating on Catalent Historical earnings data for Catalent Financial information for Catalent Catalent, Inc. ( CTLT ) Q4 2023 Earnings Call Transcript Catalent, Inc. 2023 Q4 - Resu...
2023-09-05 01:20:00 ET Summary Lifecore Biomedical has divested its food-related assets and now focuses solely on its high-quality CDMO business. The company faced a rough patch earlier this year but has since refinanced its debt, secured a major customer contract, and is on the v...
2023-09-01 18:35:47 ET Catalent (NYSE: CTLT) is one company that probably wishes the summer would never end. As August came to a close, the contract drug manufacturer's stock enjoyed a nearly 12% rise over the course of the month's final week. That's according to data compiled by ...
2023-08-30 18:37:23 ET Summary Danaher Corporation benefited from the Covid-19 period and saw strong growth, aided by bolt-on deals and reasonable leverage. The company acquired the biopharma business from General Electric in a $21 billion deal, adding highly profitable sales. ...
2023-08-30 16:45:04 ET More on Catalent Catalent: Myriad Issues To Fix Catalent gains as it enters pact with activist Elliott, to conduct business review (update) Seeking Alpha’s Quant Rating on Catalent Earnings data for Catalent Dividend for ...
2023-08-29 17:04:00 ET Contract drug manufacturer Catalent (NYSE: CTLT) provided some very effective medicine to its investors on Tuesday. The company's shares leaped almost 5% higher following the publication of its latest set of quarterly results. That compared quite favorably to ...
2023-08-29 16:02:05 ET Catalent, Inc. (CTLT) Q4 2023 Earnings Conference Call August 29 2023, 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations John Greisch - Executive Chair, Board Alessandro Maselli - President and CEO Matti M...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...